Beneficial Effects of Supplemental Nitric Oxide Donor Given during Reperfusion Period in Reperfusion-Induced Lung Injury

Eşme, Hıdır; Fidan, Hüseyin; Solak, Okan; Fh, Dilek; Demirel, Reha; Ünlü, Murat

doi:10.1055/s-2006-923978

Cited by 6 publications

(1 citation statement)

References 28 publications

(38 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other strategies of NO supplementation, indirectly via infusion of a NO donor, such as FK409 [96,97], nitroprusside [98][99][100] or nitroglycerin [78,101,102] have shown to be effective in experimental settings. However, no study so far was conducted in humans.…”

Section: No Donorsmentioning

confidence: 99%

Alterations in L-Arginine Metabolism After Lung Transplantation~!2009-11-12~!2010-03-25~!2010-05-04~!

Mehl¹,

Grasemann²

2010

TONOJ

View full text Add to dashboard Cite

Since the discovery of nitric oxide (NO) in biological systems more than 20 years ago, it became widely accepted that endogenous NO plays a key role in the regulation of a variety of physiological processes. NO is involved in reperfusion injury and chronic rejection after solid organ transplantation. Arginase is an enzyme that competes with NO synthases for the common substrate L-arginine. Increased arginase activity alters L-arginine metabolism and reduces substrate availability for NO synthases, and thereby contributes to organ dysfunction following transplantation. NO deficiency after lung transplantation impacts on perfusion and ventilation of the donor organ. L-ornithine, the product of arginase activity, is precursor for polyamine and proline biosynthesis which are both involved in airway remodeling. The purpose of this review is to summarize the current knowledge on the role of alterations in the L-arginine metabolism in lung transplantation.

show abstract